Form D · Biotechnology
Q BioMed Inc.
New York, NY · CIK 0001596062
Offering snapshot reported Dec 16, 2019 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 28, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2019 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 16, 2019 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Dec 16, 2019 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 16, 2019 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Aug 7, 2017 | Initial | $3,050,390 | No comparison | 18 | SEC filing |
| Dec 15, 2016 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-355595
Source: Form D, filed Dec 16, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Denis Corin | Director, Executive |
| William S. Rosenstadt | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Ortoli Rosenstadt Llp 366 Madison Avenue, 3 Rd Floor
New York, NY, 10017
New York, NY, 10017